Glycogen synthase kinase 3 is a potential drug target for African trypanosomiasis therapy.

Ojo, Kayode K

Glycogen synthase kinase 3 is a potential drug target for African trypanosomiasis therapy. [electronic resource] - Antimicrobial agents and chemotherapy Oct 2008 - 3710-7 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1098-6596

10.1128/AAC.00364-08 doi


Animals
Base Sequence
DNA Primers--genetics
DNA, Protozoan--genetics
Genes, Protozoan
Glycogen Synthase Kinase 3--antagonists & inhibitors
Humans
Models, Molecular
Protein Kinase Inhibitors--pharmacology
RNA Interference
Recombinant Proteins--antagonists & inhibitors
Species Specificity
Trypanosoma brucei brucei--drug effects
Trypanosomiasis, African--drug therapy